1887

Health at a Glance 2015

OECD Indicators

image of Health at a Glance 2015

This new edition of Health at a Glance presents the most recent comparable data on the performance of health systems in OECD countries. Where possible, it also reports data for partner countries (Brazil, China, Colombia, Costa Rica, India, Indonesia, Latvia, Lithuania, Russian Federation and South Africa). Compared with the previous edition, this new edition includes a new set of dashboards of health indicators to summarise in a clear and user-friendly way the relative strengths and weaknesses of OECD countries on different key indicators of health and health system performance, and also a special focus on the pharmaceutical sector. This edition also contains new indicators on health workforce migration and on the quality of health care.

English Spanish, Korean, French

.

Share of generic market

All OECD countries see the development of generic markets as a good opportunity to increase efficiency in pharmaceutical spending but many do not fully exploit the potential of generics (). In 2013, generics accounted for more than three-quarters of the volume of pharmaceuticals sold in the United States, the United Kingdom, Chile, Germany and New Zealand, while they represented less than one-quarter of the market in Luxembourg, Switzerland, Italy, and Greece.

English French

Graphs

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error